Effects of Anesthetics on High-Dose Rocuronium

Status Recruiting

Clinical Trial Summary

This study evaluates the effects of three different anesthetics on high dose rocuronium in laparoscopic cholecystectomy cases. Patients were randomly assigned to one of the propofol, desflurane, or sevoflurane groups. Train of four (TOF) and bispectral index (BIS) monitoring were used during surgery in all groups.Patients were followed until TOF and post tetanic count (PTC) values reached 1 and the time was recorded.The effect of three anesthetic drugs used on the duration of the muscle relaxant drug was investigated.

Clinical Trial Description

In recent years, studies have been published showing that by applying deep neuromuscular block during laparoscopic cholecystectomy, intraabdominal pressure can be reduced without compromising the surgical conditions, thus complications such as postoperative nausea and vomiting (PONV) and pain can be reduced. The results we obtained in our previous study showed that deep neuromuscular block achieved with a high dose of 1.2 mg/kg rocuronium allowed the operation to be performed with lower intra-abdominal pressure values, shortened the operation time, reduced PONV and pain in laparoscopic cholecystectomy cases. The most important factor affecting the depth of neuromuscular block is the dose of the neuromuscular agent. However, anesthetic agents can also affect the depth of neuromuscular blockade. The effects of muscle relaxants are enhanced when administered together with inhalation anesthetics.Propofol and sevoflurane are widely used in the maintenance of anesthesia. Unlike propofol, sevoflurane enhances the effects of some neuromuscular blocking drugs, including rocuronium. Our primary aim in this study is to evaluate the effects of sevoflurane, desflurane, or propofol, which are commonly used in anesthesia maintenance, on the duration of neuromuscular block caused by 1.2 mg/kg rocuronium, which is the dose we routinely use in anesthesia induction, in laparoscopic cholecystectomy cases. Secondary aims are to investigate its effects on intraabdominal pressures and surgical conditions, and to determine whether it reduces postoperative pain and PONV, as well as extubation and recovery times. ;

Study Design

Related Conditions & MeSH terms

Neuromuscular Blockade

Clinical Trial Details

NCT number	NCT06045559
Study type	Observational [Patient Registry]
Source	Mustafa Kemal University
Contact	Selim Turhanoglu, MD
Phone	+905325062988
Email	adat63@gmail.com
Status	Recruiting
Phase
Start date	October 2, 2023
Completion date	September 2, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05558969` - The Effect of Magnesium Use in Reversal of Neuromuscular Block With Sugammadex	N/A
Completed	`NCT03168308` - Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients	Phase 4
Not yet recruiting	`NCT03978780` - Erector Spinae Block vs. Placebo Block Study	N/A
Completed	`NCT02892045` - Mindray Neuromuscular Transmission Transducer
Completed	`NCT02912039` - Electromyographic Assessment of the TetraGraph in Normal Volunteers
Completed	`NCT03427385` - Minimum Local Anesthetic Dose for Adductor Canal Block	N/A
Completed	`NCT01450813` - The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy	N/A
Completed	`NCT00535496` - Relation Between TOF-Watch® SX and a Peripheral Nerve Stimulator After 4.0 mg.Kg-1 Sugammadex (P05698)	Phase 3
Recruiting	`NCT05794503` - Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex	Early Phase 1
Not yet recruiting	`NCT05993390` - Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients	N/A
Recruiting	`NCT04609410` - Bleeding in Laparoscopic Liver Surgery	N/A
Terminated	`NCT03649672` - The Validity and Tolerability of Awake Calibration of the TOF Watch SX Monitor	N/A
Completed	`NCT05687253` - Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery	Phase 2
Completed	`NCT05474638` - Comparison of Mechanomyographic 100 Versus 200 Hz 5 Second Tetanic Fade Ratios During Neuromuscular Block Recovery	N/A
Completed	`NCT05120999` - Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring
Completed	`NCT03572413` - The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Innate Immune Homeostasis.	Phase 4
Completed	`NCT03608436` - The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Early Quality of Recovery	Phase 4
Recruiting	`NCT02930629` - Residual Block in Postoperative Anaesthetic Care Unit	N/A
Completed	`NCT02932254` - Magnesium Sulfate Effect Following the Reversal of Neuromuscular Blockade Induced by Rocuronium With Sugammadex	Phase 4
Completed	`NCT01828385` - Effect of Magnesium on the Recovery Time of Neuromuscular Blockade With Sugammadex	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.